AB-RayBio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.4M

  • Investors
  • 5

AB-RayBio General Information

Description

Manufacturer of targeted radiopharmaceutical devices designed for therapeutic and diagnostic purposes. The company integrates small molecule discovery, AI-driven peptide screening, radiolabeling, non-clinical evaluation, and rapid clinical translation capabilities, enabling oncology researchers and clinicians to access precision-targeted solutions for unmet clinical needs in cancer treatment and diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 925, Ruquan Road
  • Binjiang District
  • Hangzhou, Zhejiang 311215
  • China
+86 135
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Number 925, Ruquan Road
  • Binjiang District
  • Hangzhou, Zhejiang 311215
  • China
+86 135

AB-RayBio Timeline

20252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AB-RayBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 26-Feb-2026 $14.4M Completed Generating Revenue
2. Early Stage VC 13-Jun-2025 Completed Generating Revenue
1. Seed Round 27-Dec-2024 Completed Startup
To view AB-RayBio’s complete valuation and funding history, request access »

AB-RayBio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zeke Venture Capital Growth/Expansion Minority
ZJVC Venture Capital Venture Capital Minority
Hangzhou Hi-Tech Financial Investment Group Venture Capital Minority
Hangzhou Industrial Investment Group Government Minority
Zing Capital(China) Growth/Expansion Minority
To view AB-RayBio’s complete investors history, request access »

AB-RayBio FAQs

  • When was AB-RayBio founded?

    AB-RayBio was founded in 2024.

  • Where is AB-RayBio headquartered?

    AB-RayBio is headquartered in Hangzhou, China.

  • What industry is AB-RayBio in?

    AB-RayBio’s primary industry is Therapeutic Devices.

  • Is AB-RayBio a private or public company?

    AB-RayBio is a Private company.

  • What is AB-RayBio’s current revenue?

    The current revenue for AB-RayBio is .

  • How much funding has AB-RayBio raised over time?

    AB-RayBio has raised $14.4M.

  • Who are AB-RayBio’s investors?

    Zeke Venture Capital, ZJVC Venture Capital, Hangzhou Hi-Tech Financial Investment Group, Hangzhou Industrial Investment Group, and Zing Capital(China) have invested in AB-RayBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process